Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Clinical (Molecular Imaging: Peptides)

  • You have access
    Detection of early esophageal neoplastic Barrett lesions with quantified fluorescence molecular endoscopy using cetuximab-800CW
    Ruben Y. Gabriels, Lisanne E. van Heijst, Wouter T. R. Hooghiemstra, Anne M. van der Waaij, Gursah Kats-Ugurlu, Arend Karrenbeld, Dominic J. Robinson, Anna Tenditnaya, Vasilis Ntziachristos, Dimitris Gorpas and Wouter B. Nagengast
    Journal of Nuclear Medicine January 5, 2023, jnumed.122.264656; DOI: https://doi.org/10.2967/jnumed.122.264656
  • You have access
    3-time-point PET-analysis of FAPI-46 in a variety of cancers
    Mahnoosh Naeimi, Peter L. Choyke, Katharina Dendl, Yuriko Mori, Fabian Staudinger, Tadashi Watabe, Stefan A Koerber, Manuel Röhrich, Juergen Debus, Clemens Kratochwil, Uwe A. Haberkorn and Frederik L Giesel
    Journal of Nuclear Medicine November 17, 2022, jnumed.122.264941; DOI: https://doi.org/10.2967/jnumed.122.264941
  • You have access
    Detecting CXCR4 expression in meningioma on 68Ga-Pentixafor PET
    Simone Krebs, Jazmin Schwartz, Christian Grommes, Robert J. Young, Heiko Schöder and Marius Mayerhoefer
    Journal of Nuclear Medicine November 10, 2022, jnumed.122.265127; DOI: https://doi.org/10.2967/jnumed.122.265127
  • 
    Phase I Trial of <sup>99m</sup>Tc-(HE)<sub>3</sub>-G3, a DARPin-Based Probe for Imaging of HER2 Expression in Breast Cancer
    You have access
    Phase I Trial of 99mTc-(HE)3-G3, a DARPin-Based Probe for Imaging of HER2 Expression in Breast Cancer
    Olga Bragina, Vladimir Chernov, Alexey Schulga, Elena Konovalova, Eugeniy Garbukov, Anzhelika Vorobyeva, Anna Orlova, Liubov Tashireva, Jens Sörensen, Roman Zelchan, Anna Medvedeva, Sergey Deyev and Vladimir Tolmachev
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 528-535; DOI: https://doi.org/10.2967/jnumed.121.262542
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire